North America Biopsy Devices Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| Market Size (2024) | USD 0.86 Billion |
| Market Size (2029) | USD 1.05 Billion |
| CAGR (2024 - 2029) | 4.00 % |
Major Players
*Disclaimer: Major Players sorted in no particular order |
North America Biopsy Devices Market Analysis
The North America Biopsy Devices Market size is estimated at USD 0.86 billion in 2024, and is expected to reach USD 1.05 billion by 2029, growing at a CAGR of 4% during the forecast period (2024-2029).
The major factors driving the growth of the market in the North America region is due to the increasing preference for minimally invasive procedures, an increase in the number of cancer cases, and initiatives undertaken by the government for early diagnosis of cancer.
Biopsy has been one of the major diagnosis techniques for cancer disorders and is widely used in the diagnosis of breast, skin, and prostate cancer. According to the Canadian Cancer Statistics 2019 report, it is estimated that nearly 1 in 2 Canadians will be diagnosed with cancer in their lifetime. An estimated 220,400 new cases of cancer are diagnosed in Canada in 2019. The number of cases in males (113,000) was expected to be slightly higher than in females (107,400).
There is also a demand for minimally invasive biopsy procedures that is rising at a significant rate in the market. The different types of technologies and products, such as biopsy guiding systems, needle-based biopsy guns, and vacuum-assisted devices are anticipated to witness the high growth during the forecast period. Thus, owing to above mentioned factors the market is expected to show significant growth over the forecast period.
North America Biopsy Devices Market Trends
This section covers the major market trends shaping the North America Biopsy Devices Market according to our research experts:
Needle-based Biopsy Instruments is Expected to Hold a Major Market Share in the Biopsy Devices Market
Needle-based biopsy holds the leading share in the market due to the increasing demand for these instruments, for acquiring samples from soft tissues of internal organs, such as breasts, kidneys, and lungs. This is poised to contribute to the growth of the overall market during the forecast period.
According to the estimates of the American Cancer Society, in 2018, there would be 1,735,350 new cancer cases diagnosed and 609,640 deaths, due to cancer in the United States. The most common cancers in the United States are breast cancer, lung cancer, prostate cancer, colorectum cancer, bladder cancer, and skin cancer.
Furthermore, according to Globocon, 1,90,667 new cancer cases were diagnosed, and 83,476 deaths were reported due to cancer in Mexico in the year 2018. Breast cancer, prostate cancer, lung and bronchus cancer, and colorectal cancer were the most common types of cancers in Mexico.
Therefore, the above benefits of needle-based biopsy guns coupled with the increasing demand for minimally invasive procedures will spur the segmental growth.
North America Biopsy Devices Industry Overview
The North America Biopsy Devices Market is fragmented competitive. The major market players operating in the biopsy devices market are Hologic, Becton, Dickinson and Company., Boston Scientific Corporation., among other players. These companies are undertaking strategies, such as product launch through technological innovations and partnerships to gain profits in the industry. Thus, the new product launches are the most preferred strategy followed by collaborations and geographical expansion for market capitalization.
North America Biopsy Devices Market Leaders
-
Becton, Dickinson and Company
-
Hologic Inc
-
Boston Scientific Corporation
-
Cook Medical
-
Argon Medical Devices
*Disclaimer: Major Players sorted in no particular order
North America Biopsy Devices Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Increasing Preference for Minimally Invasive Procedures
- 4.2.2 Increase in the Number of Cancer Cases Worldwide
- 4.2.3 Initiatives Undertaken by Government for Diagnosis
-
4.3 Market Restraints
- 4.3.1 Product Recalls
- 4.3.2 Availability of Alternative Techniques
-
4.4 Porter's Five Force Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
-
5.1 By Product
- 5.1.1 Needle-based Biopsy Instruments
- 5.1.1.1 Core Biopsy Devices
- 5.1.1.2 Aspiration Biopsy Needles
- 5.1.1.3 Vacuum-assisted Biopsy Devices
- 5.1.2 Procedure Trays
- 5.1.3 Localization Wires
- 5.1.4 Other Products
-
5.2 By Application
- 5.2.1 Breast Biopsy
- 5.2.2 Lung Biopsy
- 5.2.3 Colorectal Biopsy
- 5.2.4 Prostate Biopsy
- 5.2.5 Other Applications
-
5.3 Geography
- 5.3.1 North America
- 5.3.1.1 United States
- 5.3.1.2 Canada
- 5.3.1.3 Mexico
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 Becton, Dickinson and Company
- 6.1.2 Hologic Inc
- 6.1.3 Devicor Medical Products Inc.
- 6.1.4 Cook Medical
- 6.1.5 Boston Scientific Corporation
- 6.1.6 Intact Medical Corporation
- 6.1.7 Gallini Medical
- 6.1.8 Argon Medical Devices
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject To AvailablityNorth America Biopsy Devices Industry Segmentation
As per the scope of the report, the biopsy is a process that helps in the removal of tissue from an organ to determine the presence or extent of a disease, mostly cancerous and inflammatory conditions. This diagnostic procedure is generally performed by surgeons, radiologists, and interventional cardiologists, to confirm the presence of cancerous tissues. Therefore, the biopsy procedures can be performed for almost any organ with the help of a specific biopsy device. The North America Biopsy Devices Market is segmented by product, application, and geography.
| By Product | Needle-based Biopsy Instruments | Core Biopsy Devices |
| Aspiration Biopsy Needles | ||
| Vacuum-assisted Biopsy Devices | ||
| By Product | Procedure Trays | |
| Localization Wires | ||
| Other Products | ||
| By Application | Breast Biopsy | |
| Lung Biopsy | ||
| Colorectal Biopsy | ||
| Prostate Biopsy | ||
| Other Applications | ||
| Geography | North America | United States |
| Canada | ||
| Mexico |
North America Biopsy Devices Market Research FAQs
How big is the North America Biopsy Devices Market?
The North America Biopsy Devices Market size is expected to reach USD 0.86 billion in 2024 and grow at a CAGR of 4% to reach USD 1.05 billion by 2029.
What is the current North America Biopsy Devices Market size?
In 2024, the North America Biopsy Devices Market size is expected to reach USD 0.86 billion.
Who are the key players in North America Biopsy Devices Market?
Becton, Dickinson and Company, Hologic Inc, Boston Scientific Corporation, Cook Medical and Argon Medical Devices are the major companies operating in the North America Biopsy Devices Market.
What years does this North America Biopsy Devices Market cover, and what was the market size in 2023?
In 2023, the North America Biopsy Devices Market size was estimated at USD 0.83 billion. The report covers the North America Biopsy Devices Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the North America Biopsy Devices Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
North America Biopsy Devices Industry Report
Statistics for the 2024 North America Biopsy Devices market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. North America Biopsy Devices analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
